Madonna Rosalinda, Balistreri Carmela Rita, Geng Yong-Jian, De Caterina Raffaele
Center of Excellence on Aging (CesiMet), Institute of Cardiology, Department of Neurosciences, Imaging and Clinical Sciences, "G. d'Annunzio" University, Chieti, Italy; The Texas Heart Institute, Center for Cardiovascular Biology and Atherosclerosis Research, Department of Internal Medicine, The University of Texas Health Science Center at Houston, Houston, TX, United States.
Department of Pathobiology and Medical Biotechnologies, University of Palermo, Palermo, Italy.
Vascul Pharmacol. 2017 Mar;90:1-7. doi: 10.1016/j.vph.2017.01.004. Epub 2017 Jan 28.
Diabetic microangiopathy, including retinopathy, is characterized by abnormal growth and leakage of small blood vessels, resulting in local edema and functional impairment of the depending tissues. Mechanisms leading to the impairment of microcirculation in diabetes are multiple and still largely unclear. However, a dysregulated vascular regeneration appears to play a key role. In addition, oxidative and hyperosmolar stress, as well as the activation of inflammatory pathways triggered by advanced glycation end-products and toll-like receptors, have been recognized as key underlying events Here, we review recent knowledge on cellular and molecular pathways of microvascular disease in diabetes. We also highlight how new insights into pathogenic mechanisms of vascular damage in diabetes may indicate new targets for prevention and treatment.
糖尿病微血管病变,包括视网膜病变,其特征是小血管异常生长和渗漏,导致局部水肿以及所依赖组织的功能受损。导致糖尿病微循环障碍的机制多种多样,目前仍不清楚。然而,血管再生失调似乎起着关键作用。此外,氧化应激和高渗应激,以及由晚期糖基化终产物和Toll样受体触发的炎症途径激活,已被认为是关键的潜在事件。在此,我们综述了关于糖尿病微血管疾病细胞和分子途径的最新知识。我们还强调了对糖尿病血管损伤致病机制的新见解如何可能为预防和治疗指明新的靶点。